FTC Sends Letters to 50 More Marketers Nationwide

Coronavirus outbreak and coronaviruses influenza background as dangerous flu strain cases as a pandemic medical health risk concept with disease cells as a 3D render

Washington, D.C.—The Federal Trade Commission has sent letters to 50 more marketers nationwide, warning them to stop making unsubstantiated claims that their products and therapies can treat or prevent COVID-19, according to a press release. FTC has sent similar letters to more than 120 companies and individuals.

Letters were sent to the following companies:

Supplements and Chinese Herbal Treatments:

Homeopathic Treatments:

Related: Two More Companies Receive Warning Letters for COVID-19 Claims
Associations Submit Proposed Framework for NDI Master File
CRN, NAD End Self-Regulatory Program, Encourage Industry to Stay Vigilant

Letters were also sent to acupuncture clinics, sellers of nebulizers, companies offering ozone and intravenous therapies/hydrotherapy, and two companies offering puled electromagnetic field therapy and scalar frequencies. The full list can be found here.

The companies were advised to immediately stop making all claims, and were given 48 hours to notify the commission about the specific actions they have taken to address the agencies concerns. If the claims do not cease, FTC may seek a federal court injunction and an order requiring money to be refunded to customers.